Protective effects of acetazolamide and hyperbaric oxygenation on experimentally induced syncope.
D000086:Acetazolamide / Q000494:pharmacology*; D000293:Adolescent; D000328:Adult; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D002245:Carbon Dioxide / Q000097:blood; D002560:Cerebrovascular Circulation; D004562:Electrocardiography; D004569:Electroencephalography; D006801:Humans; D006931:Hyperbaric Oxygenation; D006985:Hyperventilation; D007023:Hypotension, Controlled; D002546:Ischemic Attack, Transient / Q000150:complications / Q000209:etiology; D008297:Male; D010101:Oxygen Consumption; D013575:Syncope / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control* / Q000628:therapy; D014636:Valsalva Maneuver
D002245:Carbon Dioxide; D000086:Acetazolamide